Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
UK may reject Roche's Avastin for advanced ovarian cancer
By:
Reuters: Company News
Posted on December 17, 2012 at 19:01 PM EST
LONDON, Dec 18 (Reuters) - Britain's healthcare cost-effectiveness watchdog said it may reject Roche Holding AG's drug Avastin for treating advanced ovarian cancer in combination with two standard chemotherapy drugs.
Read More >>
Related Stocks:
Rogers Corp.
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here